A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists
Mike Dolph, Anuja Roy, Menaka Bhor, Jaclyn Hearnden, Christina S Kwon, Anna Forsythe, Gabriel Tremblay and Andrew Briggs assess the cost of treating chronic immune thrombocytopenia. This research article, from the Journal of Comparative Effectiveness Research, is free to access exclusively for Evidence Base members.
Please sign in or register for FREE
Sign in to The Evidence Base
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>